Moving Beyond Directly Observed Therapy for Tuberculosis.
作者信息
Metcalfe John Z, O'Donnell Max R, Bangsberg David R
机构信息
Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America.
Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Medical Center, New York, New York, United States of America.
出版信息
PLoS Med. 2015 Sep 15;12(9):e1001877. doi: 10.1371/journal.pmed.1001877. eCollection 2015 Sep.
Abstract
摘要
相似文献
1
Moving Beyond Directly Observed Therapy for Tuberculosis.
PLoS Med. 2015 Sep 15;12(9):e1001877. doi: 10.1371/journal.pmed.1001877. eCollection 2015 Sep.
2
Extreme condition, extreme measures? Compliance, drug resistance, and the control of tuberculosis.
Anthropol Med. 2010 Aug;17(2):201-14. doi: 10.1080/13648470.2010.493606.
3
Video directly observed therapy: Enhancing care for patients with active tuberculosis.
Nursing. 2018 May;48(5):64-66. doi: 10.1097/01.NURSE.0000531912.91585.85.
4
Digital health technologies and adherence to tuberculosis treatment.
Bull World Health Organ. 2021 May 1;99(5):323-323A. doi: 10.2471/BLT.21.286021.
5
Factors associated with declining numbers of chronic tuberculosis excretors in Japan.
Int J Tuberc Lung Dis. 2011 Feb;15(2):169-73, i.
6
Lay health worker-supported tuberculosis treatment adherence in South Africa: an interrupted time-series study.
Int J Tuberc Lung Dis. 2011 Jan;15(1):84-9, i.
7
Managing TB in the 21st century: existing and novel drug therapies.
Ther Adv Respir Dis. 2008 Dec;2(6):401-8. doi: 10.1177/1753465808099522.
8
Gradual filling up of TB drug pipeline: how can we play our role better?
Indian J Tuberc. 2009 Jan;56(1):1-4.
9
Are second-line drugs necessary to control multidrug-resistant tuberculosis?
J Infect Dis. 2006 Nov 1;194(9):1194-6. doi: 10.1086/507910. Epub 2006 Sep 18.
10
An integrated review of directly observed therapy for tuberculosis in Latin America.
Hisp Health Care Int. 2015;13(1):46-54. doi: 10.1891/1540-4153.13.1.46.
引用本文的文献
1
Effectiveness of a mobile health application on treatment outcomes among patients with tuberculosis in Shanghai, China: a multicentre randomised controlled trial.
BMJ Glob Health. 2025 Jun 6;10(6):e018022. doi: 10.1136/bmjgh-2024-018022.
2
Digital Adherence Technologies and Differentiated Care for Tuberculosis Treatment and Their Acceptability Among Persons With Tuberculosis, Health Care Workers, and Key Informants in the Philippines: Qualitative Interview Study.
JMIR Hum Factors. 2024 Jul 23;11:e54117. doi: 10.2196/54117.
3
Patient perceptions of video directly observed therapy for tuberculosis: a systematic review.
J Clin Tuberc Other Mycobact Dis. 2023 Nov 30;35:100406. doi: 10.1016/j.jctube.2023.100406. eCollection 2024 May.
4
Barriers and Facilitators to Implementing a Digital Adherence Technology for Tuberculosis Treatment Supervision in Uganda: Qualitative Study.
J Med Internet Res. 2023 May 30;25:e38828. doi: 10.2196/38828.
5
Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa.
PLoS One. 2023 Feb 13;18(2):e0281097. doi: 10.1371/journal.pone.0281097. eCollection 2023.
6
Integrating services for HIV and multidrug-resistant tuberculosis: A global cross-sectional survey among ART clinics in low- and middle-income countries.
PLOS Glob Public Health. 2022;2(3). doi: 10.1371/journal.pgph.0000180. Epub 2022 Mar 1.
7
Acceptability, feasibility, and impact of a pilot tuberculosis literacy and treatment counselling intervention: a mixed methods study.
BMC Infect Dis. 2021 May 18;21(1):449. doi: 10.1186/s12879-021-06136-1.
8
Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomized trial in Uganda.
PLoS Med. 2021 May 6;18(5):e1003628. doi: 10.1371/journal.pmed.1003628. eCollection 2021 May.
9
Synchronous and asynchronous video observed therapy (VOT) for tuberculosis treatment adherence monitoring and support.
J Clin Tuberc Other Mycobact Dis. 2019 Apr 1;17:100098. doi: 10.1016/j.jctube.2019.100098. eCollection 2019 Dec.
10
Factors influencing completion of treatment among pulmonary tuberculosis patients.
Patient Prefer Adherence. 2019 Apr 10;13:491-496. doi: 10.2147/PPA.S198007. eCollection 2019.
本文引用的文献
1
Linezolid for XDR-TB--Final Study Outcomes.
N Engl J Med. 2015 Jul 16;373(3):290-1. doi: 10.1056/NEJMc1500286.
2
Super Learner Analysis of Electronic Adherence Data Improves Viral Prediction and May Provide Strategies for Selective HIV RNA Monitoring.
J Acquir Immune Defic Syndr. 2015 May 1;69(1):109-18. doi: 10.1097/QAI.0000000000000548.
3
Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration.
J Int AIDS Soc. 2014 Dec 15;17(1):19045. doi: 10.7448/IAS.17.1.19045. eCollection 2014.
4
Preferential adherence to antiretroviral therapy over tuberculosis treatment: a qualitative study of drug-resistant TB/HIV co-infected patients in South Africa.
Glob Public Health. 2014;9(9):1107-16. doi: 10.1080/17441692.2014.934266. Epub 2014 Jul 18.
5
Ethical aspects of directly observed treatment for tuberculosis: a cross-cultural comparison.
BMC Med Ethics. 2013 Jul 2;14:25. doi: 10.1186/1472-6939-14-25.
6
Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum.
PLoS Pathog. 2012 Jan;8(1):e1002487. doi: 10.1371/journal.ppat.1002487. Epub 2012 Jan 12.
7
Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability.
J Infect Dis. 2011 Dec 15;204(12):1951-9. doi: 10.1093/infdis/jir658. Epub 2011 Oct 21.
8
HIV treatment adherence, drug resistance, virologic failure: evolving concepts.
Infect Disord Drug Targets. 2011 Apr;11(2):167-74. doi: 10.2174/187152611795589663.
9
The complexity of the adherence-response relationship in tuberculosis treatment: why are we still in the dark and how can we get out?
Trop Med Int Health. 2011 Jun;16(6):693-8. doi: 10.1111/j.1365-3156.2011.02755.x. Epub 2011 Mar 6.
10
Preventing HIV antiretroviral resistance through better monitoring of treatment adherence.
J Infect Dis. 2008 May 15;197 Suppl 3:S272-8. doi: 10.1086/533415.
Zotero 插件